LINC00052 ameliorates acute kidney injury by sponging miR-532-3p and activating the Wnt signaling pathway.


Journal

Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617

Informations de publication

Date de publication:
24 11 2020
Historique:
received: 05 01 2020
accepted: 30 07 2020
pubmed: 25 11 2020
medline: 13 5 2021
entrez: 24 11 2020
Statut: ppublish

Résumé

Acute kidney injury (AKI) is a complex renal disease. Long non-coding RNAs (lncRNAs) have frequently been associated with AKI. In the present study, we aimed to investigate the molecular mechanism(s) of LINC00052 in AKI. We found that LINC00052 expression was significantly decreased in AKI patient serum. In addition, in a hypoxic AKI cell model, LINC00052 expression was strongly elevated. In an I/R-triggered AKI rat model, the expression of TNF-α, IL-6 and IL-1β mRNA was strongly elevated. Moreover, we predicted miR-532-3p to be targeted by LINC00052 in AKI. Overexpression of LINC00052 increased hypoxia-induced inhibition of NRK-52E cell proliferation and reversed hypoxia-triggered apoptosis. Furthermore, we found that induction of TNF-α, IL-6 and IL-1β was repressed by overexpression of LINC00052. LINC00052 decreased hypoxia-induced ROS and MDA accumulation

Identifiants

pubmed: 33231561
pii: 104152
doi: 10.18632/aging.104152
pmc: PMC7835036
doi:

Substances chimiques

MIRN532 microRNA, human 0
MicroRNAs 0
Proto-Oncogene Proteins c-myc 0
RNA, Long Noncoding 0
Reactive Oxygen Species 0
Cyclin D1 136601-57-5
Malondialdehyde 4Y8F71G49Q
Superoxide Dismutase EC 1.15.1.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

340-350

Références

J Cell Physiol. 2019 Aug;234(8):12926-12933
pubmed: 30549040
J Am Soc Nephrol. 2016 Feb;27(2):371-9
pubmed: 26561643
Oncotarget. 2017 Jun 29;8(38):63724-63737
pubmed: 28969024
Clin Sci (Lond). 2019 Jun 20;133(12):1321-1339
pubmed: 31221822
Int Immunopharmacol. 2017 Jun;47:134-140
pubmed: 28391160
J Cell Biochem. 2019 Sep;120(9):16273-16282
pubmed: 31090110
Biomed Pharmacother. 2019 Jan;109:991-999
pubmed: 30551553
Biomed Pharmacother. 2019 Mar;111:917-925
pubmed: 30841471
Eur J Clin Invest. 2016 Mar;46(3):213-26
pubmed: 26707063
Am J Clin Exp Urol. 2019 Feb 18;7(1):11-30
pubmed: 30906802
J Cell Biochem. 2019 Mar 4;:
pubmed: 30834562
Kidney Int Suppl (2011). 2014 Nov;4(1):84-90
pubmed: 26312156
J Cell Biochem. 2019 Aug;120(8):12822-12831
pubmed: 30860638
Front Oncol. 2019 May 31;9:407
pubmed: 31214490
Ann Intern Med. 2017 Nov 7;167(9):ITC66-ITC80
pubmed: 29114754
Toxins (Basel). 2010 Nov;2(11):2490-518
pubmed: 22069563
J Cell Physiol. 2019 Aug;234(8):14221-14233
pubmed: 30684280
N Engl J Med. 2014 Jul 3;371(1):58-66
pubmed: 24988558
Kidney Int. 2012 Sep;82(5):537-47
pubmed: 22622501
Mol Ther Nucleic Acids. 2019 Sep 6;17:102-112
pubmed: 31234008
Swiss Med Wkly. 2019 Jan 13;149:w14703
pubmed: 30636273
Biol Res. 2018 Sep 4;51(1):31
pubmed: 30180910
Trends Genet. 2008 Jul;24(7):361-71
pubmed: 18514358
J Am Soc Nephrol. 2005 Nov;16(11):3365-70
pubmed: 16177006
Eur J Pharmacol. 2018 Jul 15;831:20-27
pubmed: 29733821
Cell. 2012 Jun 8;149(6):1192-205
pubmed: 22682243
Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4822-4827
pubmed: 31210314
Kidney Int. 2012 May;81(9):819-25
pubmed: 21975865
J Gene Med. 2019 Aug;21(8):e3104
pubmed: 31177599
Nephron. 2019;143(2):135-147
pubmed: 31216555
Free Radic Biol Med. 2010 Dec 1;49(11):1603-16
pubmed: 20840865
Per Med. 2017 May;14(3):271-278
pubmed: 29767584
Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2353-2359
pubmed: 30964159
J Cell Physiol. 2019 Mar;234(3):2266-2276
pubmed: 30146769
Lancet. 2012 Aug 25;380(9843):756-66
pubmed: 22617274
Am J Physiol Renal Physiol. 2012 Dec 1;303(11):F1487-94
pubmed: 22993069
Oncol Res. 2017 Nov 2;25(9):1589-1599
pubmed: 28337962
Cell Biosci. 2015 Nov 16;5:63
pubmed: 26579219

Auteurs

Xiaoying Li (X)

Department of Nephrology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Qingpu 201700, Shanghai, P.R. China.

Pengxi Zheng (P)

Department of Nephrology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Qingpu 201700, Shanghai, P.R. China.

Tingting Ji (T)

Department of Nephrology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Qingpu 201700, Shanghai, P.R. China.

Bo Tang (B)

Department of Nephrology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Qingpu 201700, Shanghai, P.R. China.

Yakun Wang (Y)

Department of Nephrology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Qingpu 201700, Shanghai, P.R. China.

Shoujun Bai (S)

Department of Nephrology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Qingpu 201700, Shanghai, P.R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH